Cranial radiation can be eliminated in most children with T-cell acute lymphoblastic leukemia (T-ALL) and bortezomib potentially improves survival in children with T-cell lymphoblastic lymphoma (T-LL): Results of Children's Oncology Group (COG) trial AALL1231 Meeting Abstract


Authors: Teachey, D. T.; Devidas, M.; Wood, B. L.; Chen, Z.; Hayashi, R. J.; Annett, R. D.; Asselin, B. L.; August, K. J.; Cho, S. Y.; Dunsmore, K. P.; Fisher, B. T.; Freedman, J. L.; Galardy, P. J.; Harker-Murray, P.; Hermiston, M. L.; Horton, T. M.; Jaju, A. I.; Lam, A.; Messinger, Y. H.; Miles, R. R.; Okada, M.; Patel, S. I.; Schafer, E. S.; Schechter-Finkelstein, T.; Shimano, K. A.; Singh, N.; Steele, A. C.; Sulis, M. L.; Vargas, S. L.; Winter, S. S.; Wood, C.; McKay, P. Z.; Bollard, C. M.; Loh, M. L.; Hunger, S. P.; Raetz, E. A.
Abstract Title: Cranial radiation can be eliminated in most children with T-cell acute lymphoblastic leukemia (T-ALL) and bortezomib potentially improves survival in children with T-cell lymphoblastic lymphoma (T-LL): Results of Children's Oncology Group (COG) trial AALL1231
Meeting Title: 62nd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 136
Issue: Suppl. 1
Meeting Dates: 2020 Dec 5-8
Meeting Location: Virtual
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2020-11-05
Language: English
ACCESSION: WOS:000607205602344
DOI: 10.1182/blood-2020-134730
PROVIDER: wos
Notes: Meeting Abstract: 11 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Luisa Sulis
    43 Sulis